4.5 Review

Biohybrid robotics: From the nanoscale to the macroscale

Publisher

WILEY
DOI: 10.1002/wnan.1703

Keywords

bacteria‐ bots; biorobots; enzymatic nanomotors; hybrid robotics; muscle‐ based biorobots

Funding

  1. la Caixa Foundation [LCF/BQ/SO16/52270018]
  2. Agencia Estatal de Investigacion [CEX2018-000789-S]
  3. Generalitat de Catalunya [2017 SGR 1148]
  4. H2020 European Research Council [866348]
  5. H2020 Marie Sklodowska-Curie Actions, DNA-Bots [843998]
  6. Ministerio de Ciencia, Innovacion y Universidades (MCIU) [RTI2018-098164-B-I00]
  7. Marie Curie Actions (MSCA) [843998] Funding Source: Marie Curie Actions (MSCA)
  8. European Research Council (ERC) [866348] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Biohybrid robotics involves combining biological entities with artificial materials at different scales to create systems with enhanced performance. This technology has applications in drug delivery, biofilm removal, and developing biomimetic devices for various purposes.
Biohybrid robotics is a field in which biological entities are combined with artificial materials in order to obtain improved performance or features that are difficult to mimic with hand-made materials. Three main level of integration can be envisioned depending on the complexity of the biological entity, ranging from the nanoscale to the macroscale. At the nanoscale, enzymes that catalyze biocompatible reactions can be used as power sources for self-propelled nanoparticles of different geometries and compositions, obtaining rather interesting active matter systems that acquire importance in the biomedical field as drug delivery systems. At the microscale, single enzymes are substituted by complete cells, such as bacteria or spermatozoa, whose self-propelling capabilities can be used to transport cargo and can also be used as drug delivery systems, for in vitro fertilization practices or for biofilm removal. Finally, at the macroscale, the combinations of millions of cells forming tissues can be used to power biorobotic devices or bioactuators by using muscle cells. Both cardiac and skeletal muscle tissue have been part of remarkable examples of untethered biorobots that can crawl or swim due to the contractions of the tissue and current developments aim at the integration of several types of tissue to obtain more realistic biomimetic devices, which could lead to the next generation of hybrid robotics. Tethered bioactuators, however, result in excellent candidates for tissue models for drug screening purposes or the study of muscle myopathies due to their three-dimensional architecture. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available